(Q37782862)

23 August 2017

1 reference

title

Antiatherogenic effects of calcium-channel blockers: possible mechanisms of action (English)

1 reference

23 August 2017

P D Henry

1

1 reference

23 August 2017

1 August 1990

1 reference

Cardiovascular Drugs and Therapy

23 August 2017

1 reference

23 August 2017

4 Suppl 5

1 reference

23 August 2017

1015-1020

1 reference

Inhibition of cholesteryl ester deposition in macrophages by calcium entry blockers: an effect dissociable from calcium entry blockade

23 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF02018310

Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02018310

Prevention of transcoronary macromolecular leakage after ischemia-reperfusion by the calcium entry blocker nisoldipine. Direct observations in isolated rat hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02018310

Evidence for increased aortic plasma membrane calcium transport caused by experimental atherosclerosis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02018310

Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers

21 January 2018

1 reference

12 December 2020

Verapamil suppresses atherosclerosis in cholesterol-fed rabbits

1 reference

12 December 2020

Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2

1 reference

12 December 2020

Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture.

1 reference

12 December 2020

Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery

1 reference

12 December 2020

Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110.

1 reference

12 December 2020

Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect

1 reference

12 December 2020

Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators

1 reference

12 December 2020

Densitometric measurement of increased endothelial permeability in arteriosclerotic plaques and inhibition of permeability under the influence of two calcium antagonists

1 reference

12 December 2020

Ineffectiveness of Ca2+-antagonists nicardipine and diltiazem on experimental atherosclerosis in cholesterol-fed rabbits

1 reference

12 December 2020

Suppression of atherosclerosis in cholesterol-fed rabbits by diltiazem injection

1 reference

12 December 2020

Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110

1 reference

12 December 2020

Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells

1 reference

12 December 2020

Aspirin inhibits development of coronary atherosclerosis in cynomolgus monkeys (Macaca fascicularis) fed an atherogenic diet

1 reference

12 December 2020

The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation

1 reference

12 December 2020

Long-term effects of verapamil on aortic smooth muscle cells cultured in the presence of hypercholesterolemic serum

1 reference

12 December 2020

The pathogenesis of atherosclerosis--an update

1 reference

12 December 2020

Calcium dependency of aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. Effects of A23187, nicardipine and trifluoperazine

1 reference

12 December 2020

Effect of verapamil on accumulation of free and esterified cholesterol in the thoracic aorta of cholesterol-fed rabbits

1 reference

12 December 2020

Calcium antagonists as antiatherogenic agents

1 reference

12 December 2020

An analysis of the mechanism of local anesthetic inhibition of platelet aggregation and secretion

1 reference

12 December 2020

Effect of a sustained release formulation of diltiazem on the development of atherosclerosis in cholesterol-fed rabbits

1 reference

12 December 2020

Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism

1 reference

12 December 2020

Compensatory enlargement of human atherosclerotic coronary arteries

1 reference

12 December 2020

Antiatherogenic properties of calcium antagonists

1 reference

12 December 2020

Blood flow through vasa vasorum of coronary arteries in atherosclerotic monkeys

1 reference

12 December 2020

The effect of calcium antagonists on intimal cell proliferation in atherogenesis

1 reference

12 December 2020

Inhibition of smooth muscle cell proliferation and endothelial permeability with flunarizine in vitro and in experimental atheromas.

1 reference

12 December 2020

Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit

1 reference

12 December 2020

The effects of antihypertensive agents on serum lipids and lipoproteins

1 reference

12 December 2020

Supersensitivity of atherosclerotic rabbit aorta to ergonovine. Mediation by a serotonergic mechanism

1 reference

12 December 2020

Mouse antithrombotic assay: the effects of Ca++ channel blockers are platelet-independent

1 reference

12 December 2020

Effect of nicardipine and verapamil on in vitro albumin transport in rabbit thoracic aorta

1 reference

12 December 2020

Suppression of atherogenesis by nifedipine in the cholesterol-fed rhesus monkey

1 reference

12 December 2020

Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size

1 reference

12 December 2020

Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits

1 reference

12 December 2020

Phospholipid-induced human platelet activation: Effects of calcium channel blockers and calcium chelators

1 reference

12 December 2020

Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine

1 reference

12 December 2020

Absence of (-) [3H]desmethoxyverapamil binding sites on human platelets and lack of evidence for voltage-dependent calcium channels

1 reference

12 December 2020

Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats

1 reference

12 December 2020

Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits

1 reference

12 December 2020

Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta

1 reference

12 December 2020

Hypertension-accelerated atherogenesis in cholesterol-fed rabbits

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02018310

1 reference

23 August 2017

1 reference

PubMed ID

2076387